Goh KY, Lee WX, Choy SM, Priyadarshini GK, Chua K, Tan QH, Low SY, Chin HS, Wong CS, Huang SY, Fu NY, Nishiyama J, Harmston N, Tang HW
Tirzepatide adds GIP receptor activation, making it a dual agonist
Although GLP-1 RAs are not currently approved for dermatologic indications, their combined metabolic and immunologic effects support their potential use in inflammatory skin diseases
Fuller, thicker hair
For patients on steroids, this genetic insight helps PlexusDx specialists choose the GLP-1 medication most likely to overcome steroid-driven hunger and weight gain
Johne A, et al